TWYNSTA® FOR HEALTHCARE PROFESSIONALS — Twynsta (telmisartan/amlodipine) Tablets are indicated for the treatment of hypertension, alone or with other antihypertensive agents. They may be used in patients whose blood pressure is not adequately controlled on antihypertensive monotherapy. TWYNSTA tablets may also be used as initial therapy in patients who are likely to need multiple drugs to achieve their blood pressure goals. Read full indication statement Twynsta Home Important Safety Information Prescribing Information Clinical Efficacy Studies & Trials — Twynsta® (telmisartan/amlodipine) Tablets — Efficacy

TWYNSTA Efficacy

Review clinical study results for TWYNSTA—A fixed-dose ARB/CCB combining telmisartan and amlodipine for the treatment of hypertension

Twynsta® (telmisartan/amlodipine) Tablets were studied in 1 placebo-controlled and 2 active-controlled trials. Click on the tabs below to review clinical study results.

Reference 1 Reference 2 Reference 3

The concomitant use of telmisartan and amlodipine has been evaluated for safety in more than 3700 patients with hypertension.

Review TWYNSTA safety data

Visit the MICARDIS for Healthcare Professionals Web site to access tools and resources designed to help you create individualized treatment plans for your hypertensive patients.

Go to www.MicardisPro.com

TWYNSTA Prescribing Information MICARDIS Prescribing Information Return to Top